Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Quanterix Corp (QTRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10yQuanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health.

CEO: E. Kevin Hrusovsky
https://www.quanterix.com
Price: $15.75 Metrics
OS: 22.0 M
Market cap: $346 M
Net cash: $56.8 M $2.59 per share
EV: $289 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues22.917.612.2
            Revenue growth30.1%44.4% 
Cost of goods sold7.76.35.7
Gross profit15.111.36.5
            Gross margin66.2%64.2%53.5%
Selling, general and administrative19.712.510.2
EBIT-26.0-21.7-14.5
            EBIT margin-113.7%-123.5%-119.2%
Pre-tax income-27.0-23.2-15.9
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-27.0-23.2-15.9
            Net margin-118.1%-131.8%-130.9%
 
Diluted EPS($0.01)($0.01)($0.01)
Shares outstanding (diluted)3,757.02,142.81,813.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy